This inventor holds 1 USPTO granted patent. Top assignee: Seroctin Research & Technology, Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Norman C. Negus
Introduction
Norman C. Negus is a notable inventor based in Cora, Wyoming. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve various therapeutic purposes. His work focuses on enhancing human well-being through innovative chemical solutions.
Latest Patents
Negus holds a patent for "Compounds for use as antidepressants, aphrodisiacs and adjunctive therapies in humans." This patent describes phenolic compounds that are covalently linked to various functional groups. These compounds have been found to act as antidepressants and improve mood, enhance sexual desire and performance, assist in weight loss, and provide adjunctive therapy for substance abuse and addiction. The compounds can be derived from monocotyledonous plants, such as corn in their early growth stages, as well as from animal sources like the velvet antler tips of deer and elk.
Career Highlights
Negus is associated with Seroctin Research & Technology, Inc., where he continues to explore innovative solutions in the pharmaceutical industry. His work has the potential to impact the lives of many individuals seeking effective treatments for mood disorders and related issues.
Collaborations
Throughout his career, Negus has collaborated with esteemed colleagues, including Mark J. Rosenfeld and Patricia J. Berger. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Norman C. Negus exemplifies the spirit of innovation in the pharmaceutical field. His contributions through patented compounds highlight the importance of research and development in improving human health and well-being.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile